Has the FDA issued any Lipitor diabetes warning?

Published on November 12, 2013 by Sandy Liebhard

Text-Size:A A A+

 

Yes. In 2012, the FDA ordered Pfizer, Inc. to add new warnings to the Lipitor label regarding an increased risk of new-onset diabetes in patients who took Lipitor. The FDA took action after a study published in JAMA: Internal Medicine reported that post-menopausal women treated with the statin may be at an increased risk for developing the disease.